Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
BMC Medicine|February 13, 2018
The human fetal adrenal produces cortisol but no detectable aldosterone throughout the second trimesterZoe C Johnston, Michelle Bellingham, Panagiotis Filis, et al.
Molecular Cancer Therapeutics|September 21, 2006
Real-time gene expression analysis in human xenografts for evaluation of histone deacetylase inhibitorsAnn Beliën, Stefanie De Schepper, Wim Floren, et al.
Community Dentistry and Oral Epidemiology|February 8, 2023
Evaluating childsmile, Scotland's National Oral Health Improvement Programme for childrenAlastair J Ross, Andrea Sherriff, Jamie Kidd, et al.
Journal of the Neurological Sciences|September 23, 2016
Environmental, dietary and case-control study of Nodding Syndrome in Uganda: A post-measles brain disorder triggered by malnutrition?Peter S Spencer, Rajarshi Mazumder, Valerie S Palmer, et al.
European Journal of Endocrinology|May 23, 2009
The role of ghrelin and ghrelin-receptor gene variants and promoter activity in type 2 diabetesEdwin A Garcia, Peter King, Kally Sidhu, et al.
Cell Metabolism|September 11, 2012
BBS-induced ciliary defect enhances adipogenesis, causing paradoxical higher-insulin sensitivity, glucose usage, and decreased inflammatory responseVincent Marion, Anaïs Mockel, Charlie De Melo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2005
Accurate discrimination of Barrett's esophagus and esophageal adenocarcinoma using a quantitative three-tiered algorithm and multimarker real-time reverse transcription-PCRMichael Mitas, Jonas S Almeida, Kaidi Mikhitarian, et al.
Bioanalysis|November 19, 2010
The 2nd Calibration and Validation Group workshop on recent issues in good laboratory practice bioanalysisNatasha Savoie, Brian P Booth, Troy Bradley, et al.
Human Mutation|May 28, 2010
Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma familiesSusana Igreja, Harvinder S Chahal, Peter King, et al.
Molecular Cancer Therapeutics|April 19, 2017
Oncogenic Characterization and Pharmacologic Sensitivity of Activating Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations to the Selective FGFR Inhibitor ErdafitinibJayaprakash D Karkera, Gabriela Martinez Cardona, Katherine Bell, et al.
Pageof 7